China-based BeiGene Ltd, listed on Nasdaq (NASDAQ: BGNE, HKG: 6160, SHA: 688235), has announced a significant brand transformation, changing its Nasdaq ticker symbol to “ONC” effective January 2, 2025. This move is accompanied by a proposed English name change to BeOne Medicines Ltd, highlighting the company’s dedication to delivering innovative oncology medicines on a global scale.
Continuity in CUSIP Number and Stock Codes
Despite the rebranding, BeiGene Ltd’s CUSIP number will remain the same, ensuring continuity for investors and stakeholders. The company’s stock codes and names will also remain unchanged on The Stock Exchange of Hong Kong and the STAR Market of the Shanghai Stock Exchange. This consistency aims to maintain familiarity and ease the transition for shareholders and the investment community.
Emphasizing Global Oncology Commitment
The rebranding to BeOne Medicines Ltd and the adoption of the “ONC” ticker symbol underscore the company’s long-standing commitment to the field of oncology. The new name and ticker symbol are designed to reflect the company’s focus on providing innovative cancer treatments and reinforcing its identity as a global player in oncology medicine.-Fineline Info & Tech
